Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: A Study of Isatuximab-based Therapy in Participants With Lymphoma [Phase 1, Phase 2]
A Phase 1/2 study of isatuximab-based therapy for lymphoma was terminated, with results posted in October 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial update evaluating Rituximab, Carmustine, Cytarabine, Etoposide, & Melphalan with stem cell transplantation for lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma [Phase 1, Phase 2]
Clinical trial update for Rituxan and BEAM with autologous peripheral blood progenitor transplant in indolent lymphoma (Phase 1/Phase 2) com…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells [Phase 4]
Clinical trial update for PEG-rhG-CSF used to mobilize autologous hematopoietic stem cells in lymphoma patients (Phase 4).
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma [Phase 2]
Phase 2 clinical trial investigating hetrombopag for secondary prevention of thrombocytopenia induced by XPO-1 inhibitors in lymphoma patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial update involving a monoclonal antibody therapy, combination chemotherapy, and peripheral stem cell transplant in lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B) [Phase 2]
Phase 2 MATCH subprotocol study evaluating palbociclib for cancers with CCND1-3 amplification; the trial is active but not recruiting with r…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]
A Phase 1/ Phase 2 trial evaluating HLX301, a TIGIT×PD-L1 bispecific, in locally advanced/metastatic solid tumors or lymphoma; current statu…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2) [Phase 2]
A Phase 2 MATCH-subprotocol trial is evaluating trametinib for cancers with GNAQ or GNA11 mutations; the study is active/not recruiting and …
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib plus gemcitabine in relapsed mantle cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1) [Phase 2]
Phase 2 MATCH subprotocol study evaluating trametinib for cancers with NF1 genetic changes has posted results; the trial is currently not re…
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant [Phase 3]
Phase 3 trial evaluating whether Lactobacillus plantarum can prevent acute graft-versus-host disease in children undergoing donor stem cell …
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia [Phase 2]
Phase 2 clinical trial update for venetoclax combined with IM2 in relapsed/refractory T lymphoblastic lymphoma/leukemia.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy for AIDS-related lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the modified BFM-95 regimen as first-line chemotherapy in adults with T-lymphoblastic lymphoma is ongoin…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial update evaluating denileukin diftitox for lymphomas has been completed.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer [NA]
Clinical trial update on a geriatric assessment intervention aimed at reducing toxicity in older patients with advanced cancer; results post…
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders [Phase 2]
Phase 2 clinical trial update on donor peripheral stem cell transplantation for patients with advanced hematologic cancers and related disor…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) [Phase 1, Phase 2]
Phase 1/2 study evaluating Epacadostat in combination with Nivolumab in select advanced cancers; results have been posted following completi…
-
CLINICAL_TRIALS withdrawal · 2023-04-21Clinical Trial Update: A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]
A Phase 3 trial combining Zilovertamab with Ibrutinib for relapsed or refractory mantle cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating CD19 and CD22 targeted CAR-T therapy for relapsed/refractory B-cell leukemia and lymphoma with safety and efficac…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial update evaluating a CD19-targeted CAR-T therapy for relapsed/refractory CD19-positive B cell leukemia and lymphom…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders [NA]
This clinical trial update reports on allogeneic hematopoietic cell transplantation from matched unrelated donors in patients with advanced …
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: Pedometer Activity Monitoring After ASCT [Phase 2]
Phase 2 clinical trial evaluating pedometer-based activity monitoring after autologous stem cell transplantation in lymphoma and myeloma pat…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT [Phase 2, Phase 3]
Phase 2/Phase 3 trial assessing CD45RA-depleted T-cell infusion to prevent infections after TCRab/CD19-depleted allogeneic hematopoietic ste…